Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001172661-25-001361·Deep Track Capital, LP
Schedule 13G ownership disclosure
DIANTHUS THERAPEUTICS INC COM
Common Stock, $0.001 Par Value · CUSIP: 252828108
Event date: 2025-03-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deep Track Capital, LP
Shares: 2,357,702.00 · Class: 7.34%
- Deep Track Biotechnology Master Fund, Ltd.
Shares: 2,357,702.00 · Class: 7.34%
- David Kroin
Shares: 2,357,702.00 · Class: 7.34%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-001361
- Form type
- SCHEDULE 13G
- Filer
- Deep Track Capital, LP
- CIK
- CIK 1856083
- Filed
- Mar 24, 2025
- Reporting period
- Mar 17, 2025
- Description
- Schedule 13G beneficial ownership